12
56
Growth Score 12 in past quarter
-2 pts
Heat Score 56 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
200417
Dorian Therapeutics develops and works on senoblockers.
- Jeff George: Board DirectorPast Role: Performance Health, CEO
- Maddalena Adorno: Co-Founder & CEO
About the Company
Dorian Therapeutics offers treatment and solutions for age-associated diseases such as diabetes, alzheimer's, arthritis, sarcopenia, osteoarthritis, osteoporosis, and more. They also offer cellular and immunotherapy services.
Women Founded
Women Led